Biocomposites launches SYNICEM™ spacers in Canada

Ready-to-use preformed antibiotic loaded spacers for hip, knee and shoulder revisions

Choice of Charnley and Müller hip spacer designs, and left and right geometries for each knee

KEELE, England, Jan. 29, 2026 /PRNewswire/ -- Biocomposites, an international medical devices company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue, today announces the launch of its SYNICEM™ hip, knee and shoulder preformed spacers in Canada.

SYNICEM™ antibiotic loaded preformed spacers are designed to preserve articular space, limb length and joint stability during two-stage revision procedures, while aiding in the treatment of infection by bacteria sensitive to gentamicin. Precision-engineered for consistency and structural uniformity, they are sterile, ready-to-use in under a minute, and reduce the time demands and mechanical risks associated with traditional intra-operative molded or handmade spacers. 

Available in a comprehensive range of sizes and styles for case-by-case flexibility, the SYNICEM™ spacer range includes a choice of Charnley and Müller hip spacer designs, and specific left and right geometries for each knee. SYNICEM™ spacers have been successfully used for more than 20 years in over 70 countries, helping surgeons save operative time and manage challenging infection cases.

Michael Harris, Chief Executive Officer of Biocomposites, said: "Making SYNICEM™ preformed antibiotic loaded spacers available to surgeons in Canada, less than three months after launching them in the U.S., is a source of pride for the team at Biocomposites. The quality and consistency of the SYNICEM™ spacer range reflects our long-standing focus on precision engineering and dependable performance, with the aim of supporting clinicians and improving care for patients with complex needs."

About Biocomposites
Biocomposites is an international medical device company that engineers, manufactures and markets world leading products for use in infection management in bone and soft tissue. Based in Keele, UK, it has global operations across Europe, South America, USA, Canada, China and India. Biocomposites is a world leader in the development of innovative calcium compounds and bone cements for surgical use. Its products regenerate bone and target infection risks across a variety of specialties, including musculoskeletal infection, orthopaedics, trauma, spine, foot and ankle, podiatry and sports injuries. Biocomposites' products are now used in over 1 million procedures per annum and sold in more than 100 countries around the world. Please visit biocomposites.com to learn more.

View original content:https://www.prnewswire.com/news-releases/biocomposites-launches-synicem-spacers-in-canada-302673005.html

SOURCE Biocomposites Ltd